Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael L. Hayes is active.

Publication


Featured researches published by Michael L. Hayes.


Nature Biotechnology | 1999

Production of goats by somatic cell nuclear transfer

Alexander Baguisi; Esmail Behboodi; David Melican; Julie Pollock; Margaret M. Destrempes; Christine Cammuso; Jennifer L. Williams; Scott Nims; Catherine A. Porter; Patricia Midura; Monica J. Palacios; Sandra L. Ayres; R.S. Denniston; Michael L. Hayes; Carol Ziomek; Harry M. Meade; R.A. Godke; William G. Gavin; E.W. Overstrom; Yann Echelard

In this study, we demonstrate the production of transgenic goats by nuclear transfer of fetal somatic cells. Donor karyoplasts were obtained from a primary fetal somatic cell line derived from a 40-day transgenic female fetus produced by artificial insemination of a nontransgenic adult female with semen from a transgenic male. Live offspring were produced with two nuclear transfer procedures. In one protocol, oocytes at the arrested metaphase II stage were enucleated, electrofused with donor somatic cells, and simultaneously activated. In the second protocol, activated in vivo oocytes were enucleated at the telophase II stage, electrofused with donor somatic cells, and simultaneously activated a second time to induce genome reactivation. Three healthy identical female offspring were born. Genotypic analyses confirmed that all cloned offspring were derived from the donor cell line. Analysis of the milk of one of the transgenic cloned animals showed high-level production of human antithrombin III, similar to the parental transgenic line.


Journal of Chromatography A | 2013

Monoclonal antibody heterogeneity analysis and deamidation monitoring with high-performance cation-exchange chromatofocusing using simple, two component buffer systems

Xuezhen Kang; Joseph P. Kutzko; Michael L. Hayes; Douglas D. Frey

The use of either a polyampholyte buffer or a simple buffer system for the high-performance cation-exchange chromatofocusing of monoclonal antibodies is demonstrated for the case where the pH gradient is produced entirely inside the column and with no external mixing of buffers. The simple buffer system used was composed of two buffering species, one which becomes adsorbed onto the column packing and one which does not adsorb, together with an adsorbed ion that does not participate in acid-base equilibrium. The method which employs the simple buffer system is capable of producing a gradual pH gradient in the neutral to acidic pH range that can be adjusted by proper selection of the starting and ending pH values for the gradient as well as the buffering species concentration, pKa, and molecular size. By using this approach, variants of representative monoclonal antibodies with isoelectric points of 7.0 or less were separated with high resolution so that the approach can serve as a complementary alternative to isoelectric focusing for characterizing a monoclonal antibody based on differences in the isoelectric points of the variants present. Because the simple buffer system used eliminates the use of polyampholytes, the method is suitable for antibody heterogeneity analysis coupled with mass spectrometry. The method can also be used at the preparative scale to collect highly purified isoelectric variants of an antibody for further study. To illustrate this, a single isoelectric point variant of a monoclonal antibody was collected and used for a stability study under forced deamidation conditions.


Biotechnology and Bioengineering | 2013

Identification and quantitation of vesivirus 2117 particles in bioreactor fluids from infected Chinese hamster ovary cell cultures

Yongchang Qiu; Nathan Jones; Michelle Busch; Peng Pan; Jesse Keegan; Weichang Zhou; Mark Plavsic; Michael L. Hayes; John M. McPherson; Tim Edmunds; Kate Zhang; Robert J. Mattaliano

The prevention of adventitious agent contamination is a top priority throughout the entire biopharmaceutical production process. For example, although viral contamination of cell banks or cell cultures is rare, it can result in serious consequences (e.g., shutdown and decontamination of manufacturing facilities). To ensure virus free production, numerous in vivo and in vitro adventitious agent assays and biophysical characterizations such as electron microscopy are conducted on cell banks, raw materials, process materials, and drug substances throughout the manufacturing process. Molecular assays such as PCR and other nucleotide‐based techniques are also routinely used for screening and identification of any viral agents. However, modern techniques in protein identification of complex protein mixtures have not yet been effectively integrated throughout the industry into current viral testing strategies. Here, we report the identification and quantitation of Vesivirus 2117 particles in bioreactor fluid from infected Chinese hamster ovary cell cultures by global protein sequencing using mass spectrometry in combination with multi‐dimensional liquid‐chromatography. Following mass spectrometric data acquisition and rigorous data analysis, six virus specific peptides were identified. These peptides were fragments of two structural proteins, capsid protein pre‐cursor (four unique peptides) and small structural protein (two unique peptides), from the same species: Vesivirus 2117. Using stable heavy isotope‐labeled peptides as internal standards, we also determined the absolute concentration of Vesivirus particles in the bioreactor fluid and the ratio of two capsid proteins (VP1:VP2) in the particles as approximately 9:1. The positive identification of Vesivirus 2117 was subsequently confirmed by RT‐PCR. Biotechnol. Bioeng. 2013; 110: 1342–1353.


Biotechnology and Bioengineering | 2012

Remodeling the oligosaccharides on β-glucocerebrosidase using hydrophobic interaction chromatography and applications of hydroxyl ethyl starch for improving remodeling and enhancing protein stability

Frank Riske; Andrea Hamilton; Cheng Zhang; Michael L. Hayes

In this article, we describe a hydrophobic interaction chromatography (HIC) method to remodel the carbohydrates on recombinant human β‐glucocerebrosidase (GCR) and the use of hydroxyl ethyl starch (HES) an ethylated starch polymer, to improve this process. GCR is a therapeutic protein used in the treatment of Gaucher disease, a life threatening condition in which patients lack sufficient functional levels of this enzyme. Gaucher disease is the most common inherited lysosomal storage disorder resulting in hepatomegaly, splenomegaly, and bone and lung pathology due to the accumulation of glucosylceramide in the lysosomes of macrophages (Beutler and Grabowski, 2001 ). The oligosaccharide remodeling of GCR, performed on HIC using three enzymes that remove sugars, increases macrophage uptake through the mannose receptor and thereby lowers its therapeutic dose versus unmodified GCR (Furbish et al., 1981 ; Van Patten et al., 2007 ). In this article we describe findings that the addition of HES lowered the amounts of three deglycosylating enzymes needed for remodeling GCR. HES also stabilized the activity of α‐glucosidase, α‐galactosidase, and GCR under conditions in which these three enzymes rapidly lose activity in the absence of this polymer. Circular dichroism (CD) and second derivative UV spectroscopy revealed that the secondary and tertiary structure of α‐glucosidase was unchanged while for GCR there was a slight compaction of the secondary structure but no apparent affect on the tertiary structure. The thermal stability of both GCR and α‐glucosidase were enhanced by HES as both molecules showed an increased transition midpoint (Tm). Biotechnol. Bioeng. 2012; 109:1217–1227.


Nature Biotechnology | 1991

Transgenic expression of a variant of human tissue-type plasminogen activator in goat milk: purification and characterization of the recombinant enzyme.

Julie Denman; Michael L. Hayes; Christine O'Day; Timothy Edmunds; Catherine Bartlett; Shirish Hirani; Karl M. Ebert; Katherine Gordon; John M. McPherson


Archive | 1997

Purification of biologically active peptides from milk

Joseph P. Kutzko; Michael L. Hayes; Lee T. Sherman


Archive | 1993

Enhanced in vivo uptake of glucocerebrosidase

BethAnn Friedman; Michael L. Hayes


Archive | 1992

Production of enzymatically active glucocerebrosidase from recombinant cells

Michael L. Hayes; Debra A. Barngrover; James R. Rasmussen


Archive | 2002

Method of producing latent antithrombin iii

Kimberly Bishop; Michael L. Hayes; Julie Pollock; Patten Scott Van


Archive | 2006

Use polysaccharides for promotion of enzymatic activity

Frank Riske; Michael L. Hayes; Gary Lazarus

Collaboration


Dive into the Michael L. Hayes's collaboration.

Researchain Logo
Decentralizing Knowledge